NO895220D0 - Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.

Info

Publication number
NO895220D0
NO895220D0 NO895220A NO895220A NO895220D0 NO 895220 D0 NO895220 D0 NO 895220D0 NO 895220 A NO895220 A NO 895220A NO 895220 A NO895220 A NO 895220A NO 895220 D0 NO895220 D0 NO 895220D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
benzene derivatives
therapeutic active
active benzene
Prior art date
Application number
NO895220A
Other languages
English (en)
Other versions
NO171847B (no
NO171847C (no
NO895220L (no
Inventor
Jean-Claude Breliere
Pierre Casellas
Serge Lavastre
Raymond Paul
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO895220D0 publication Critical patent/NO895220D0/no
Publication of NO895220L publication Critical patent/NO895220L/no
Priority to MX9203624A priority Critical patent/MX9203624A/es
Publication of NO171847B publication Critical patent/NO171847B/no
Publication of NO171847C publication Critical patent/NO171847C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C225/18—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/38—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO895220A 1988-12-30 1989-12-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater NO171847C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9203624A MX9203624A (es) 1988-12-30 1992-06-26 Derivados de benceno y composiciones farmaceuticas que los contienen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8817538A FR2641276B1 (fr) 1988-12-30 1988-12-30 Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant

Publications (4)

Publication Number Publication Date
NO895220D0 true NO895220D0 (no) 1989-12-22
NO895220L NO895220L (no) 1990-07-02
NO171847B NO171847B (no) 1993-02-01
NO171847C NO171847C (no) 1993-05-12

Family

ID=9373667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895220A NO171847C (no) 1988-12-30 1989-12-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater

Country Status (22)

Country Link
US (2) US5354781A (no)
EP (1) EP0376850B1 (no)
JP (1) JP2588977B2 (no)
KR (1) KR0178366B1 (no)
AR (1) AR247548A1 (no)
AU (1) AU618439B2 (no)
CA (1) CA2006896C (no)
CZ (1) CZ419291A3 (no)
DE (1) DE68905171T2 (no)
DK (1) DK174505B1 (no)
ES (1) ES2055138T3 (no)
FI (1) FI98811C (no)
FR (1) FR2641276B1 (no)
GR (1) GR3007357T3 (no)
HK (1) HK1000541A1 (no)
HU (1) HU211155A9 (no)
IE (1) IE63689B1 (no)
IL (1) IL92889A (no)
NO (1) NO171847C (no)
NZ (1) NZ232010A (no)
PT (1) PT92761B (no)
ZA (1) ZA899955B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658821B1 (fr) * 1990-02-28 1994-09-16 Jouveinal Sa Nouvelles propanamines, leurs proprietes pharmacologiques et leur application a des fins therapeutiques, notamment antidiarrheuiques.
FR2742051B1 (fr) * 1995-12-06 1998-02-06 Synthelabo Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
FR2794742B1 (fr) * 1999-06-11 2005-06-03 Sanofi Synthelabo Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2887454B1 (fr) * 2005-06-28 2009-06-05 Sanofi Aventis Sa Combinaisons antitumorales contenant des derives du taxane et des sigma ligands
DE102006031813B4 (de) 2006-07-07 2011-04-28 Christian-Albrechts-Universität Zu Kiel Verwendung basischer Acetophenone als Hemmstoffe von NO-Synthasen
US11344511B2 (en) * 2016-07-27 2022-05-31 Case Western Reserve University Compounds and methods of promoting myelination
US10918610B2 (en) * 2017-12-22 2021-02-16 Case Western Reserve University Compounds and methods of promoting myelination
US20220024851A1 (en) 2018-12-03 2022-01-27 Convelo Therapeutics, Inc. Crystalline forms of multicyclic compounds and uses thereof
AU2021342704A1 (en) 2020-09-17 2023-05-04 Meletios Therapeutics Compounds for treating virus infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468761A (fr) * 1965-08-05 1967-02-10 Amines et esters carbamiques acétyléniques
AT316516B (de) * 1970-12-09 1974-07-10 Sumitomo Chemical Co Verfahren zur Herstellung von neuen Aminoalkoholen und von deren Säureadditionssalzen
GB1430063A (en) * 1972-03-24 1976-03-31 Wallis Separators Separator
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
IT1113391B (it) * 1979-05-09 1986-01-20 Maggioni Farma Derivati fenilcicloesanici ad attivita' antidepressiva
DE3019497A1 (de) * 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen Aminopropiophenon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3541181A1 (de) * 1985-11-21 1987-05-27 Basf Ag Propylamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide

Also Published As

Publication number Publication date
PT92761A (pt) 1990-06-29
FI98811C (fi) 1997-08-25
US5354781A (en) 1994-10-11
NO171847B (no) 1993-02-01
CA2006896A1 (en) 1990-06-30
IE63689B1 (en) 1995-05-31
ES2055138T3 (es) 1994-08-16
FI98811B (fi) 1997-05-15
EP0376850A1 (fr) 1990-07-04
AR247548A1 (es) 1995-01-31
IL92889A (en) 1994-02-27
FI896342A0 (fi) 1989-12-29
AU618439B2 (en) 1991-12-19
IL92889A0 (en) 1990-09-17
NO171847C (no) 1993-05-12
DK674589A (da) 1990-07-01
US5449693A (en) 1995-09-12
JP2588977B2 (ja) 1997-03-12
NO895220L (no) 1990-07-02
IE894209L (en) 1990-06-30
GR3007357T3 (no) 1993-07-30
AU4737989A (en) 1990-07-05
CA2006896C (en) 1998-06-02
HK1000541A1 (en) 1998-04-03
DE68905171D1 (de) 1993-04-08
NZ232010A (en) 1992-03-26
ZA899955B (en) 1990-09-26
FR2641276A1 (fr) 1990-07-06
DK674589D0 (da) 1989-12-29
CZ419291A3 (en) 1993-05-12
DK174505B1 (da) 2003-04-28
HU211155A9 (en) 1995-10-30
PT92761B (pt) 1996-01-31
DE68905171T2 (de) 1993-06-17
JPH032116A (ja) 1991-01-08
KR0178366B1 (ko) 1999-05-15
EP0376850B1 (fr) 1993-03-03
KR900009580A (ko) 1990-07-04
FR2641276B1 (fr) 1991-07-12

Similar Documents

Publication Publication Date Title
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO893616L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO895220D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO890607L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
NO880492D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske triazolpyrimidinderivater.

Legal Events

Date Code Title Description
MK1K Patent expired